<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N omega-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (0.3-10 mg/kg), a nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthase inhibitor, was administered i.p. to gerbils subjected to 10 min of carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> seven times at 5 min, 3, 6, 24, 48, 72 and 96 h after recirculation </plain></SENT>
<SENT sid="1" pm="."><plain>Histopathological examination of the brains obtained 6 days after reflow disclosed that N omega-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> possesses an ability to mitigate neuronal <z:mp ids='MP_0001651'>necrosis</z:mp> in the CA1 subfield of the hippocampus with an optimal dosage of 3 mg/kg </plain></SENT>
<SENT sid="2" pm="."><plain>These results strongly suggest that NO synthase activation is at least partly involved in the pathogenetic cellular mechanisms underlying selective neuronal <z:mp ids='MP_0001651'>necrosis</z:mp> following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>